期刊文献+

脂联素对糖尿病大血管病变的影响 被引量:1

Effect of adiponectin on diabetic macro-angiopathy
下载PDF
导出
摘要 脂联素(adiponectin,APN)是脂肪细胞分泌的一种细胞因子,通过结合APN受体1和受体2发挥抗炎、抗糖尿病、抗动脉粥样硬化的作用。1型糖尿病病人和正常人的血清APN水平相似,但2型糖尿病病人的APN水平显著降低。2型糖尿病的心血管并发症明显增加,且2型糖尿病合并心血管病变患者的APN水平明显低于2型糖尿病但无心血管病变者,提示糖尿病大血管病变可能与APN缺乏有关。 Adiponectin (APN) is an adipocyte secreting cytokine, which exerts anti-inflammatory, anti-diabetic,and anti-atherosclerotic effects via combining with adiponectin receptor-1 and 2. The se- rum adiponectin concentration is similar between type 1 diabetes and normal, but significantly decreased in type 2 diabetes. Cardiovascular complications are evidently augmented in patients with type 2 diabetes. APN levels are significantly lower in cases of cardiovascular diseases combined with type 2 diabetes than those without type 2 diabetes, suggesting that macro-vascular lesions may be related to the lack of APN. Illustrating the mechanism of APN effect on macro-vascular may contribute to provide a new idea that macro-angiopathy is less in type 1 diabetes compare to type 2 diabetes, even though fluctuate in a large range. glucose
出处 《国际病理科学与临床杂志》 CAS 2008年第5期452-455,共4页 Journal of International Pathology and Clinical Medicine
基金 湖南省自然科学基金(07JJ6160) 湖南省卫生厅课题(2007117)~~
关键词 脂联素 脂联素受体 糖尿病 大血管病变 adiopnectin adiopnectin receptor diabetes macrovascular
  • 相关文献

参考文献21

  • 1Kuhl J, Hilding A, Ostenesn CG, et al. Characterisation of subjects with early adiponectin of glucose tolerance in the Stockholm diabetes prevention programme : the impact of sex and type 2 diabetes heredity[ J ]. Diabetologia, 2005, 48 (2) :35-40.
  • 2Westerbacka J, Corner A, Tiikklanell M, et al. Women and men have similar amounts of liver and intra-abdnminal fat despite more subcutaneous fal in women:implications for differences in marker of cardiovascular risk [ J ]. Diabetologia, 2004, 47 (3) : 1360-1369.
  • 3Pinar H, Basu S, Hotmire K, et al. High molecular weight multimer complexes and vascular expression contribute to high adiponectin in the fetus[J]. J Clin Endocrin Metab,2008, 93(7) :2885- 2890.
  • 4Guzik TJ, Manglaat D, Korbul R. Adipocytokines novel link between inflammation and vascular function? [ J]. J Physiol Pharmacol, 2006, 57(4) :505-528.
  • 5Yamauchi M, Kamon J, Waki H, et al. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPAR gamma)deficiency and PPAR gamma agonist improve insulin resistance[ J]. J Biol Chem,2001,276(44) :41245-41254.
  • 6Fernandez M, Triplitt C, Wajcberg E, et al. Addition of pioglitazone and ramipril to inlensive insulin therapy in type 2 diabetic patients improves vascular dysfunction by different mechanisms [ J ]. Diabetes Care, 2008, 31 ( 1 ) :121-127.
  • 7Ouedraogo R, Wu X, Xu SQ, et al. Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells : evidence for involvement of a cAMP signaling pathway [ J ]. Diabetes, 2006, 55 ( 6 ) : 1840-1846.
  • 8Kobayashi H. Ouchi N, Kihara S, et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin[ J ]. Circ Res, 2004, 94 (4) :e27-e31.
  • 9Wang Y, Lam KS, Xu JY, et al. Adiponectin inhibits cell proliferation by intleracting with several growth factosr in an oligomerization-dependent manner[ J ]. J Biol Chem, 2005, 280 ( 18 ) : 18341 - 18347.
  • 10Matsuda M, Shimomura I, Sara M, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis[J]. J Biol Chem, 2002, 277(40) :37487-37491.

二级参考文献1

共引文献4

同被引文献76

  • 1Afita Y, Kihara S, Ouchi N, et al. Adipocyte-derived plasma protein adiponectin act as a platelet-derived growth faetor-BB-binding protein and regulates growth factor-induced eomnmon postreeeptor singaling vascular smooth muscle cell[ J]. Circulation, 2002, 105 (24) : 2893-2898.
  • 2Lusis AJ. Atherosclerosis [ J ]. Nature, 2000, 407 ( 6801 ) : 233- 241.
  • 3Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin [ J]. Circulation, 1999, 100(25) :2473-2476.
  • 4Kobashi C, Urakaze M, Kishida M, et al. Adiponectin inhibits endothelial synthesis of interleukin-8[ J]. Circ Res, 2005,97(12) : 1245-1252.
  • 5Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway [ J]. Circulation, 2000, 102 ( 11 ) : 1296-1301.
  • 6Ouedraogo R, Wu X, Xu SQ, et al. Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway [J]. Diabetes, 2006, 55(6) :1840-1846.
  • 7Ouchi N, Kihara S, Arita Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages [ J]. Circulation, 2001, 103 (8) : 1057-1063.
  • 8Yokota T, Oritani K, Takahashi I, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages[ J]. Blood, 2000, 96(5) : 1723-1732.
  • 9Wulster-Radcliffe MC, Ajuwon KM, Wang J, et al. Adiponectin differentially regulates cytokines in porcine macrophages [ J ]. Biochem Biophys Res Commun, 2004, 316 (3) :924-929.
  • 10Yamaguchi N, Argueta JG, Masuhiro Y, et al. Adiponectin inhibits toll like receptor family-induced signaling[ J]. FEBS Lett, 2005, 579(30) :6821-6826.

引证文献1

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部